A recent pause in U.S. sales of Varipulse is hampering the company’s bid to catch up in one of the industry’s fastest-growing ...

ALBANY, N.Y. ( NEWS10) — A new device is transforming the type of treatment some heart patients with atrial fibrillation receive. Doctors say it’s safer to use and improving outcomes for those who ...

A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...

Kestra Medical recently filed a form S-1 to confirm its intent to go public through an initial public offering (IPO).

We are very pleased to be working with NAMSA and leveraging their vascular clinical and regulatory expertise to execute this ...